Bolte Axel
- SEC CIK
- 0001579247
No open-market purchases or sales filed in the past year.
Current role at each company
- INZY Inozyme Pharma, Inc.Directoras of Jul 3, 2025
- ISEE IVERIC bio, Inc.Directoras of Jul 13, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bolte Axel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INZY Inozyme Pharma, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2022 (view filing) | Apr 19 | 1 day | Bolte AxelChief Executive Officer | PPurchase | +67.8K | $3.69 | +$250.0K | +35.5%258.6K after |